Request Deal Involvement

Seroba Life Sciences led a €21m Series B round in Coave Therapeutics.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

MEDiSTRAVA Consulting

pr advisors

MEDiSTRAVA Consulting

Weil Gotshal and Manges

legal advisors

Weil Gotshal and Manges

or

Principals

COAVE THERAPEUTICS

target

COAVE THERAPEUTICS

THEA OPEN INNOVATION

bidder

THEA OPEN INNOVATION

FUND+

bidder

FUND+

KURMA PARTNERS

bidder

KURMA PARTNERS

IDINVEST PARTNERS

bidder

IDINVEST PARTNERS

GO CAPITAL LLC

bidder

GO CAPITAL LLC

SHAM INNOVATION

bidder

SHAM INNOVATION

SEROBA LIFE SCIENCES

bidder

SEROBA LIFE SCIENCES

EUREKARE

bidder

EUREKARE

OMNES CAPITAL SAS

bidder

OMNES CAPITAL SAS

V-BIO VENTURES

bidder

V-BIO VENTURES

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Seroba Life Sciences led a €21m Series B round in Coave Therapeutics.